Gabrielius Misurenkovas, a 12-year-old from east London, suffers from recessive dystrophic epidermolysis bullosa (RDEB), a debilitating skin condition. He participated in a clinical trial where he received stem cells, resulting in quicker wound healing and reduced skin inflammation. RDEB affects approximately 150 children in the UK, with no current disease-modifying treatments available. Patients often manage by dressing wounds. Complications from the disorder can lead to skin cancer, which is a leading cause of death for RDEB patients. Gabrielius expressed enthusiasm for the trial, hoping it would enable him to enjoy activities like football.
"Gabrielius did really well on the trial. His wounds healed quicker, and his skin was less red and inflamed. His skin was also less itchy which also reduced him scratching."
"I wanted to take part in the trial as I was excited to see if it could help improve my condition and so I could do more of the things I enjoy, like playing football and spending time with my friends."
Collection
[
|
...
]